Anti-TIGIT (tiragolumab biosimilar) mAb
| Common Name |
MTIG-7192-A, MTIG-7192A, MTIG7192A, RG-6058, RO-7092284, RO7092284 |
|---|---|
| Buffer |
Preservative: 0.1% Procline 300 Constituents: 50% Glycerol; PBS, pH 7.4; 0.1% BSA |
| Guarantee | 12 months from date of dispatch |
| Catalog Number | BME100026 |
|---|---|
| Package | 50 μl $80.00 ; 100 μl $160.00 |
| Synonyms | TIGIT,VSIG9,VSTM3 |
| Host Species | Homo sapiens |
| IgG type | IgG1 |
| Clonality | Monoclonal |
| Formulation | Liquid |
| Purification | Purified from cell culture supernatant by affinity chromatography |
| Reactivity | Human |
| Applications | ELISA |
| Recommended Dilutions | ELISA 1:5000-10000 |
| Storage | Store at -20°C (Avoid repeated freezing and thawing) |
| Usage | Research use only |
| Images |
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human TIGIT, His tagged protein (PME100506) can bind Anti-TIGIT Neutralizing antibody in a linear range of 1.6-200.0 ng/ml.
|
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Datasheet | Download | COA | Download |
|---|---|---|---|
| MSDS | Download | ||
简体中文
English